Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan
H Isobe, K Mori, K Minato, H Katsura… - Lung Cancer: Targets …, 2017 - Taylor & Francis
Background Recommended therapies for advanced/metastatic non-small cell lung cancer
(NSCLC) have changed with the advent of targeted therapies. The objectives of this …
(NSCLC) have changed with the advent of targeted therapies. The objectives of this …
Trends in Survival Rates of Non–Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020
Importance Over the past 10 years, treatment of non–small cell lung cancer (NSCLC) has
been continually revolutionized. However, standard clinical trials may not reflect current …
been continually revolutionized. However, standard clinical trials may not reflect current …
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective …
J Shimizu, K Masago, H Saito… - … in medical oncology, 2020 - journals.sagepub.com
Background: Molecular diagnostic testing is necessary to guide optimal first-line treatment.
The number of patients who receive first-line treatment based on biomarker analysis in …
The number of patients who receive first-line treatment based on biomarker analysis in …
[HTML][HTML] Systemic treatment patterns with advanced or recurrent non–small cell lung cancer in Japan: a retrospective hospital administrative database study
F Wang, S Mishina, S Takai, TK Le, K Ochi, K Funato… - Clinical …, 2017 - Elsevier
Purpose Data on the treatment of non–small cell lung cancer (NSCLC) in real-world clinical
practice in Japan are limited. This large-scale, retrospective cohort study examined data on …
practice in Japan are limited. This large-scale, retrospective cohort study examined data on …
Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: baseline results of an observational study …
PA Schnabel, E Smit, J de Castro Carpeño… - Lung Cancer, 2012 - Elsevier
FRAME is a prospective observational study of first-line treatments for advanced non-small
cell lung cancer (NSCLC). This interim analysis examines the influence of histology and …
cell lung cancer (NSCLC). This interim analysis examines the influence of histology and …
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China
C Xue, Z Hu, W Jiang, Y Zhao, F Xu, Y Huang, H Zhao… - Lung Cancer, 2012 - Elsevier
INTRODUCTION: Treatment choice for NSCLC in China has not previously been reported.
This paper explores the clinical practice and adherence to treatment guidelines for NSCLC …
This paper explores the clinical practice and adherence to treatment guidelines for NSCLC …
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology …
AP Abernethy, A Arunachalam, T Burke, C McKay… - PloS one, 2017 - journals.plos.org
Purpose To establish a baseline for care and overall survival (OS) based upon
contemporary first-line treatments prescribed in the era before the introduction of immune …
contemporary first-line treatments prescribed in the era before the introduction of immune …
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
DH Lee, MS Tsao, KO Kambartel, H Isobe, MS Huang… - PLoS …, 2018 - journals.plos.org
Background The goals of this multinational retrospective study were to describe treatment
patterns and survival outcomes by receipt of molecular testing and molecular status of …
patterns and survival outcomes by receipt of molecular testing and molecular status of …
Treatment patterns for advanced non–small-cell lung cancer after platinum-containing therapy in US community oncology clinical practice
C McKay, T Burke, X Cao, AP Abernethy… - Clinical Lung Cancer, 2016 - Elsevier
Background Knowledge of the real-world treatment patterns for non–small-cell lung cancer
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …
(NSCLC) can identify quality-of-care gaps and guide resource allocation needs. Our …
Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients: A Real-world Evidence Study
D Yusuf, RN Walton, M Hurry, C Farrer… - American journal of …, 2020 - journals.lww.com
Background: Most patients with stage III non–small cell lung cancer (NSCLC) develop
metastases and succumb to their cancer. Approaches to the treatment of stage III disease …
metastases and succumb to their cancer. Approaches to the treatment of stage III disease …